Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3791862 Title: FORMULATIONS DE PROTÉINES LIQUIDES CONTENANT DES AGENTS ABAISSANT LA VISCOSITÉ

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
202052502
WO application number:
Type:
European patent granted for BE
Status:
Unitary Effect Registered
Publication number:
3791862
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
01/07/2024
Link to UPP Register:
European Patent Register
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
02/09/2024
Unitary Effect Date:
29/05/2024
Unitary Effect Registration Date:
02/09/2024
Unitary Effect Rejection Decision Date:
Re-establishment of Rights (EPO level) Filing Date:
Re-establishment of rights EPO Decision:
Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Explanatory Text UE:
Date of filing of the action at the UPC:
Action:
Date of decision given by the UPC:
Decision given by the UPC:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC number:
Date of appeal on a decision:
Decision after appeal:
Date of decision on an appeal:
Date of legal effect of the lapse:
Kind of lapse:
Date of Revocation (UP level):
Date of request on revocation:
Kind of revocation:
Decision on revocation request:
Reason for request for re-establishment of rights:

Dates

Filing date:
11/09/2014
Grant date:
29/05/2024
EP publication date:
17/03/2021
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
29/05/2024
EP B1 publication date:
29/05/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
11/09/2034

Applicant

Name:
Eagle Biologics, Inc.
Legal Form:
From:
29/05/2024
Address:
47 Moulton Street, Cambridge, MA 02138, United States (US)
To:

Inventor

1

Name:
LARSON, Alyssa M.
Legal Form:
Address:
Dana Point, CA California 92629, United States (US)

2

Name:
LOVE, Kevin
Legal Form:
Address:
Somerville, MA Massachusetts 02145, United States (US)

3

Name:
WEIGHT, Alisha K.
Legal Form:
Address:
Mill Creek, WA Washington 98012, United States (US)

4

Name:
CRANE, Alan
Legal Form:
Address:
Waban, MA Massachusetts 02468, United States (US)

5

Name:
LANGER, Robert S.
Legal Form:
Address:
Newton, MA Massachusetts 02459, United States (US)

6

Name:
KLIBANOV, Alexander M.
Legal Form:
Address:
Boston, MA Massachusetts 02110, United States (US)

Priority

1

Priority patent number:
201462030521 P
Priority date:
29/07/2014
Priority country:
United States (US)

2

Priority patent number:
201462026497 P
Priority date:
18/07/2014
Priority country:
United States (US)

3

Priority patent number:
201462008050 P
Priority date:
05/06/2014
Priority country:
United States (US)

4

Priority patent number:
201461988005 P
Priority date:
02/05/2014
Priority country:
United States (US)

5

Priority patent number:
201461946436 P
Priority date:
28/02/2014
Priority country:
United States (US)

6

Priority patent number:
201461943197 P
Priority date:
21/02/2014
Priority country:
United States (US)

7

Priority patent number:
201461940227 P
Priority date:
14/02/2014
Priority country:
United States (US)

8

Priority patent number:
201361876621 P
Priority date:
11/09/2013
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/08; A61K 47/18; A61K 39/395; C07K 1/14; A61K 9/00; A61K 39/00; A61K 9/19; A61K 38/00; A61K 47/20;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2024/10
Publication date:
04/06/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
UP1
Journal edition number:
2024/19
Publication date:
09/12/2024
Description:
European patent with accepted unitary effect request

European Patent Bulletin

1

Issue number:
202422
Publication date:
29/05/2024
Description:
Grant (B1)

2

Issue number:
202428
Publication date:
10/07/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202432
Publication date:
07/08/2024
Description:
Unitary Effect Request Receipt

4

Issue number:
202440
Publication date:
02/10/2024
Description:
Unitary Effect Request Acceptance

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type